Michael S. Avumegah

SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein

Eduardo A. Albornoz, Alberto A. Amarilla, Naphak Modhiran et al. · Molecular Psychiatry · 2022 · 174 citations · Full text

Life Sciences, Infectious Diseases, Neuroscience +17

Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial

Keith J. Chappell, Francesca L. Mordant, Zheyi Li et al. · The Lancet Infectious Diseases · 2021 · 121 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +12

Preclinical development of a molecular clamp‐stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2

Daniel Watterson, Danushka K. Wijesundara, Naphak Modhiran et al. · Clinical & Translational Immunology · 2021 · 61 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

The changing epidemiology worldwide of<i>Mycobacterium ulcerans</i>

D. O’Brien, Isabelle Jeanne, Kim R. Blasdell et al. · Epidemiology and Infection · 2018 · 55 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +12

Rapid Response Subunit Vaccine Design in the Absence of Structural Information

Danushka K. Wijesundara, Michael S. Avumegah, Julia Lackenby et al. · Frontiers in Immunology · 2020 · 19 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17